Growth Patterns, Segment Analysis, and Competitive Approaches Influencing the Image-Guided Radiation Therapy Market

The image-guided radiation therapy market is on a trajectory of steady expansion as technological advancements and increased demand for targeted cancer treatments continue to evolve. Understanding the current market size, key drivers, influential players, and emerging trends offers valuable insights into how this specialized sector is shaping the future of oncology treatment.

Projected Growth and Market Size of Image-Guided Radiation Therapy
The image-guided radiation therapy market is anticipated to grow consistently over the next several years, reaching a value of $2.48 billion by 2030. This growth represents a compound annual growth rate (CAGR) of 4.4%. Several factors contribute to this positive outlook, including the incorporation of artificial intelligence in treatment planning and imaging processes. Additionally, there is a rising preference for non-invasive cancer therapies, increased funding toward state-of-the-art radiotherapy centers, wider acceptance of proton and particle therapy, and greater accessibility to cancer care services in emerging economies. Key trends expected to shape the market during this period include enhanced precision in radiation delivery, integration of real-time imaging in radiation treatments, personalized cancer treatment plans, wider use of stereotactic and proton-based therapies, and a stronger focus on minimizing radiation-induced side effects.

Download a free report of the image-guided radiation therapy market report:
https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Important Forces Propelling the Image-Guided Radiation Therapy Market
The growing integration of AI technologies is revolutionizing treatment planning and imaging accuracy within the market. This advancement allows clinicians to deliver highly precise radiation doses tailored to individual patient needs, improving treatment outcomes and reducing side effects.
Meanwhile, the demand for less invasive cancer therapies continues to rise as patients and providers seek effective treatments with fewer complications and faster recovery times. This shift is encouraging broader adoption of image-guided radiation therapy solutions worldwide.

Leading Companies Driving Innovation in Image-Guided Radiation Therapy
Several key players dominate this market, including Hitachi Ltd., Toshiba Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., GE Healthcare Company, Varian Medical Systems Inc., Elekta AB, Canon Medical Systems R&D (Dalian) Co. Ltd., Accuray Incorporated, Ion Beam Applications S.A., Brainlab AG, ViewRay Technologies Inc., Mevion Medical Systems Inc., RaySearch Laboratories AB, Vision RT Ltd., Sun Nuclear Corporation, IZI Medical Products LLC, Eckert & Ziegler BEBIG GmbH, C-RAD AB, Standard Imaging Inc., CIVCO Radiotherapy Inc., RTsafe Solutions Ltd., ASG Superconductors S.p.A., Mirada Medical Corporation, and RefleXion Medical Inc.
In a notable development from October 2023, Elekta AB, a Swedish company specializing in precision radiotherapy and brachytherapy systems, acquired the Xoft business from iCAD Inc. for about $5.5 million. This acquisition enables Elekta to integrate Xoft's low-energy X-ray electronic brachytherapy (eBx) technology into its portfolio, expanding radiation therapy options with enhanced access to intraoperative and minimally shielded treatments. Xoft's Axxent eBx system delivers localized radiation through a miniaturized X-ray source for various cancers such as breast, skin, gynecological, and brain tumors.

View the full image-guided radiation therapy market report:
https://www.thebusinessresearchcompany.com/report/image-guided-radiation-therapy-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Innovations and Future Trends Boosting Market Expansion
Manufacturers in the ophthalmic medical lasers space are focusing on developing next-generation intraoperative radiotherapy (IORT) platforms that improve precision, workflow efficiency, and patient safety during cancer treatments. These advanced systems deliver targeted radiation directly to tumor sites during surgical procedures, significantly reducing exposure to surrounding healthy tissues and enabling more controlled treatment.
For instance, in April 2025, ZEISS, a German medical technology company, secured FDA 510(k) clearance for its INTRABEAM 700 system. This robotic-assisted IORT platform is designed for neuro-oncology and breast cancer surgeries and features enhanced imaging integration, improved ergonomic design, and greater control over radiation delivery, supporting surgeons in delivering highly accurate intraoperative therapy.

Segment Analysis Highlighting Key Drivers in Image-Guided Radiation Therapy
This market is segmented by product type, procedure, application, and end user, each contributing uniquely to market growth.
Product types include 4D gating and 4D radiation therapy systems, linear accelerators (LINAC), PET and MRI-guided radiation therapy, portal imaging, and CT scanning.
Procedural segments cover intensity-modulation radiation therapy, 3D conformal radiation therapy, stereotactic therapy, proton beam therapy, and particle therapy.
Applications span treatment for lung cancer, prostate cancer, head and neck cancer, gynecological cancer, gastrointestinal cancer, and other malignancies.
End users are primarily hospitals and independent radiotherapy centers.
Subdivisions under product types include various specific technologies such as conventional and advanced LINAC systems, PET/CT-guided and MRI-guided radiation therapy, electronic and conventional portal imaging, and CT imaging methods like cone beam CT for radiation therapy planning.

Geographic Outlook and Regional Market Trends
While detailed regional growth figures are not provided here, the market's expansion is expected to be influenced by increasing investments in advanced radiotherapy infrastructure and technology adoption across diverse global regions, including developed and emerging markets. This trend reflects a broader global effort to improve cancer treatment outcomes through precision medicine and innovative radiation therapies.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.